SLC2A3 and cancer: The mutation of the P53-gene in cancer cells lead to amplified expression of GLUT-1, GLUT-3, and GLUT-4 and consequently to increased glucose uptake in cancer cells and in consequence to a higher [18F]FDG uptake in PET [36, 37, 44].